Fassett RG - Search Results

1

Biomarkers in chronic kidney disease: a review.

Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE. Fassett RG, et al. Kidney Int. 2011 Oct;80(8):806-21. doi: 10.1038/ki.2011.198. Epub 2011 Jun 22. Kidney Int. 2011. PMID: 21697815 Free article. Review.

2

Homocysteine-lowering therapy in renal disease.

Austen SK, Coombes JS, Fassett RG. Austen SK, et al. Among authors: fassett rg. Clin Nephrol. 2003 Dec;60(6):375-85. doi: 10.5414/cnp60375. Clin Nephrol. 2003. PMID: 14690253 Review.

3

Homocysteine and cardiovascular disease in renal disease.

Austen SK, Coombes JS, Fassett RG. Austen SK, et al. Among authors: fassett rg. Nephrology (Carlton). 2003 Dec;8(6):285-95. doi: 10.1111/j.1440-1797.2003.00210.x. Nephrology (Carlton). 2003. PMID: 15012699 Review.

4

The relationship between antioxidant supplements and oxidative stress in renal transplant recipients: a review.

Blackhall ML, Coombes JS, Fassett R. Blackhall ML, et al. ASAIO J. 2004 Sep-Oct;50(5):451-7. doi: 10.1097/01.mat.0000138077.90404.c8. ASAIO J. 2004. PMID: 15497384 Review.

5

No relationship between low-density lipoproteins and endothelial function in hemodialysis patients.

Dalton BS, Fassett RG, Geraghty DP, De Ryke R, Coombes JS. Dalton BS, et al. Among authors: fassett rg. Int J Cardiol. 2005 Mar 18;99(2):307-14. doi: 10.1016/j.ijcard.2004.02.004. Int J Cardiol. 2005. PMID: 15749192

6

Cyclosporine A induced changes to plasma and erythrocyte antioxidant defences.

Fletcher LA, Fassett RG, Richards RS, Coombes JS. Fletcher LA, et al. Among authors: fassett rg. Redox Rep. 2005;10(1):2-8. doi: 10.1179/135100005X21543. Redox Rep. 2005. PMID: 15829105 Free article.

7

Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients.

Blackhall ML, Fassett RG, Sharman JE, Geraghty DP, Coombes JS. Blackhall ML, et al. Among authors: fassett rg. Nephrol Dial Transplant. 2005 Sep;20(9):1970-5. doi: 10.1093/ndt/gfh875. Epub 2005 Jul 5. Nephrol Dial Transplant. 2005. PMID: 15998657 Clinical Trial.

8

Cyclosporine A-induced changes to erythrocyte redox balance is time course-dependent.

Lexis LA, Richards RS, Fassett RG, Coombes JS. Lexis LA, et al. Among authors: fassett rg. Basic Clin Pharmacol Toxicol. 2005 Sep;97(3):135-40. doi: 10.1111/j.1742-7843.2005.pto_973120.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 16128906 Free article.

9

Acute exposure to cyclosporine does not increase plasma homocysteine in rats.

Austen SK, Fletcher LA, Fassett RG, Booth C, Coombes JS. Austen SK, et al. Among authors: fassett rg. Transplant Proc. 2005 Dec;37(10):4543-6. doi: 10.1016/j.transproceed.2005.11.012. Transplant Proc. 2005. PMID: 16387165

10

Antioxidant supplementation enhances erythrocyte antioxidant status and attenuates cyclosporine-induced vascular dysfunction.

Lexis LA, Fenning A, Brown L, Fassett RG, Coombes JS. Lexis LA, et al. Among authors: fassett rg. Am J Transplant. 2006 Jan;6(1):41-9. doi: 10.1111/j.1600-6143.2005.01154.x. Am J Transplant. 2006. PMID: 16433755 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters